Cell-cycle regulators and the Ki-67 labeling index can predict the response to chemoradiotherapy and the survival of patients with locally advanced squamous cell carcinoma of the esophagus

Hiroya Takeuchi, Soji Ozawa, Nobutoshi Ando, Yuukou Kitagawa, Masakazu Ueda, Masaki Kitajima

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Background: We investigated whether aberrant p53 and p16 expression, the Ki-67 labeling index (LI), and int-2/cyclin D1 gene amplification predict the response to chemoradiotherapy (CRT) in patients with locally advanced esophageal squamous cell carcinoma (ESCC). Methods: p53 and p16 expression status, the Ki-67 LI, and int-2/cyclin D1 amplification were assessed by immunohistochemical staining and slot blot analysis in pretreatment endoscopic biopsy specimens of 41 patients with T4 or M1 Lym (distant lymph node metastasis) ESCC. All patients received a course of chemotherapy (5-fluorouracil and cisplatin) with radiotherapy. Results: The CRT therapeutic response rate was 71%, and resection after CRT was successful in 15 of the cases in which the CRT effect was significant. The cumulative survival rate after CRT in the p53-negative patients was significantly higher than in the p53-positive patients (P = .037). The mean Ki-67 LI in the CRT response cases was significantly higher than in the CRT no-response cases (P = .023). Multivariate regression analysis revealed high Ki-67 LI to be an independent variable linked to a pathologic complete response to CRT (P = .033). The cumulative survival rate after CRT in the group that was p53-negative and int-2/cyclin D1 amplification-positive was significantly higher than in the other groups (P = .008). Conclusions: Evaluating predictive factors in pretreatment endoscopic biopsy specimens may allow selection of more suitable multimodal treatment for ESCC patients and improve their quality of life.

Original languageEnglish
Pages (from-to)792-800
Number of pages9
JournalAnnals of Surgical Oncology
Volume10
Issue number7
DOIs
Publication statusPublished - 2003

Fingerprint

Chemoradiotherapy
Esophagus
Squamous Cell Carcinoma
Cell Cycle
Survival
Cyclin D1
Survival Rate
bcl-1 Genes
Biopsy
Combined Modality Therapy
Gene Amplification
Fluorouracil
Cisplatin
Radiotherapy
Multivariate Analysis
Lymph Nodes
Regression Analysis
Quality of Life
Staining and Labeling
Neoplasm Metastasis

Keywords

  • Chemoradiotherapy
  • Esophageal cancer
  • int-2/Cyclin D1 amplification
  • Ki-67
  • p16
  • p53

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Cell-cycle regulators and the Ki-67 labeling index can predict the response to chemoradiotherapy and the survival of patients with locally advanced squamous cell carcinoma of the esophagus. / Takeuchi, Hiroya; Ozawa, Soji; Ando, Nobutoshi; Kitagawa, Yuukou; Ueda, Masakazu; Kitajima, Masaki.

In: Annals of Surgical Oncology, Vol. 10, No. 7, 2003, p. 792-800.

Research output: Contribution to journalArticle

@article{1691d39df7ab4811a01c18f949d55d9e,
title = "Cell-cycle regulators and the Ki-67 labeling index can predict the response to chemoradiotherapy and the survival of patients with locally advanced squamous cell carcinoma of the esophagus",
abstract = "Background: We investigated whether aberrant p53 and p16 expression, the Ki-67 labeling index (LI), and int-2/cyclin D1 gene amplification predict the response to chemoradiotherapy (CRT) in patients with locally advanced esophageal squamous cell carcinoma (ESCC). Methods: p53 and p16 expression status, the Ki-67 LI, and int-2/cyclin D1 amplification were assessed by immunohistochemical staining and slot blot analysis in pretreatment endoscopic biopsy specimens of 41 patients with T4 or M1 Lym (distant lymph node metastasis) ESCC. All patients received a course of chemotherapy (5-fluorouracil and cisplatin) with radiotherapy. Results: The CRT therapeutic response rate was 71{\%}, and resection after CRT was successful in 15 of the cases in which the CRT effect was significant. The cumulative survival rate after CRT in the p53-negative patients was significantly higher than in the p53-positive patients (P = .037). The mean Ki-67 LI in the CRT response cases was significantly higher than in the CRT no-response cases (P = .023). Multivariate regression analysis revealed high Ki-67 LI to be an independent variable linked to a pathologic complete response to CRT (P = .033). The cumulative survival rate after CRT in the group that was p53-negative and int-2/cyclin D1 amplification-positive was significantly higher than in the other groups (P = .008). Conclusions: Evaluating predictive factors in pretreatment endoscopic biopsy specimens may allow selection of more suitable multimodal treatment for ESCC patients and improve their quality of life.",
keywords = "Chemoradiotherapy, Esophageal cancer, int-2/Cyclin D1 amplification, Ki-67, p16, p53",
author = "Hiroya Takeuchi and Soji Ozawa and Nobutoshi Ando and Yuukou Kitagawa and Masakazu Ueda and Masaki Kitajima",
year = "2003",
doi = "10.1245/ASO.2003.10.014",
language = "English",
volume = "10",
pages = "792--800",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "7",

}

TY - JOUR

T1 - Cell-cycle regulators and the Ki-67 labeling index can predict the response to chemoradiotherapy and the survival of patients with locally advanced squamous cell carcinoma of the esophagus

AU - Takeuchi, Hiroya

AU - Ozawa, Soji

AU - Ando, Nobutoshi

AU - Kitagawa, Yuukou

AU - Ueda, Masakazu

AU - Kitajima, Masaki

PY - 2003

Y1 - 2003

N2 - Background: We investigated whether aberrant p53 and p16 expression, the Ki-67 labeling index (LI), and int-2/cyclin D1 gene amplification predict the response to chemoradiotherapy (CRT) in patients with locally advanced esophageal squamous cell carcinoma (ESCC). Methods: p53 and p16 expression status, the Ki-67 LI, and int-2/cyclin D1 amplification were assessed by immunohistochemical staining and slot blot analysis in pretreatment endoscopic biopsy specimens of 41 patients with T4 or M1 Lym (distant lymph node metastasis) ESCC. All patients received a course of chemotherapy (5-fluorouracil and cisplatin) with radiotherapy. Results: The CRT therapeutic response rate was 71%, and resection after CRT was successful in 15 of the cases in which the CRT effect was significant. The cumulative survival rate after CRT in the p53-negative patients was significantly higher than in the p53-positive patients (P = .037). The mean Ki-67 LI in the CRT response cases was significantly higher than in the CRT no-response cases (P = .023). Multivariate regression analysis revealed high Ki-67 LI to be an independent variable linked to a pathologic complete response to CRT (P = .033). The cumulative survival rate after CRT in the group that was p53-negative and int-2/cyclin D1 amplification-positive was significantly higher than in the other groups (P = .008). Conclusions: Evaluating predictive factors in pretreatment endoscopic biopsy specimens may allow selection of more suitable multimodal treatment for ESCC patients and improve their quality of life.

AB - Background: We investigated whether aberrant p53 and p16 expression, the Ki-67 labeling index (LI), and int-2/cyclin D1 gene amplification predict the response to chemoradiotherapy (CRT) in patients with locally advanced esophageal squamous cell carcinoma (ESCC). Methods: p53 and p16 expression status, the Ki-67 LI, and int-2/cyclin D1 amplification were assessed by immunohistochemical staining and slot blot analysis in pretreatment endoscopic biopsy specimens of 41 patients with T4 or M1 Lym (distant lymph node metastasis) ESCC. All patients received a course of chemotherapy (5-fluorouracil and cisplatin) with radiotherapy. Results: The CRT therapeutic response rate was 71%, and resection after CRT was successful in 15 of the cases in which the CRT effect was significant. The cumulative survival rate after CRT in the p53-negative patients was significantly higher than in the p53-positive patients (P = .037). The mean Ki-67 LI in the CRT response cases was significantly higher than in the CRT no-response cases (P = .023). Multivariate regression analysis revealed high Ki-67 LI to be an independent variable linked to a pathologic complete response to CRT (P = .033). The cumulative survival rate after CRT in the group that was p53-negative and int-2/cyclin D1 amplification-positive was significantly higher than in the other groups (P = .008). Conclusions: Evaluating predictive factors in pretreatment endoscopic biopsy specimens may allow selection of more suitable multimodal treatment for ESCC patients and improve their quality of life.

KW - Chemoradiotherapy

KW - Esophageal cancer

KW - int-2/Cyclin D1 amplification

KW - Ki-67

KW - p16

KW - p53

UR - http://www.scopus.com/inward/record.url?scp=0642280658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0642280658&partnerID=8YFLogxK

U2 - 10.1245/ASO.2003.10.014

DO - 10.1245/ASO.2003.10.014

M3 - Article

VL - 10

SP - 792

EP - 800

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 7

ER -